Created at Source Raw Value Validated value
June 25, 2024, noon usa

a. moderately ill covid-19 patient and asymptomatic to mild covid-19 patent having multiple comorbidity inclusion criteria 1. hospital admitted patients tested positive covid-19 within 24 hours in the laboratory by rt-pcr. 2. patients with asymptomatic, mild to moderate illness of covid-19. 3. age group 18 year and above. 4. consent of the patients, wish to be included in the study willingly.

a. moderately ill covid-19 patient and asymptomatic to mild covid-19 patent having multiple comorbidity inclusion criteria 1. hospital admitted patients tested positive covid-19 within 24 hours in the laboratory by rt-pcr. 2. patients with asymptomatic, mild to moderate illness of covid-19. 3. age group 18 year and above. 4. consent of the patients, wish to be included in the study willingly.

Nov. 16, 2021, 6:30 p.m. usa

a. moderately ill covid-19 patient and asymptomatic to mild covid-19 patent having multiple comorbidity inclusion criteria hospital admitted patients tested positive covid-19 within 24 hours in the laboratory by rt-pcr. patients with asymptomatic, mild to moderate illness of covid-19. age group 18 year and above. consent of the patients, wish to be included in the study willingly.

a. moderately ill covid-19 patient and asymptomatic to mild covid-19 patent having multiple comorbidity inclusion criteria hospital admitted patients tested positive covid-19 within 24 hours in the laboratory by rt-pcr. patients with asymptomatic, mild to moderate illness of covid-19. age group 18 year and above. consent of the patients, wish to be included in the study willingly.

May 5, 2021, 11:25 a.m. usa

a. moderately ill covid-19 patient and asymptomatic to mild covid-19 patent having multiple comorbidity inclusion criteria 1. hospital admitted patients tested positive covid-19 within 24 hours in the laboratory by rt-pcr. 2. patients with asymptomatic, mild to moderate illness of covid-19. 3. age group 18 year and above. 4. consent of the patients, wish to be included in the study willingly.

a. moderately ill covid-19 patient and asymptomatic to mild covid-19 patent having multiple comorbidity inclusion criteria 1. hospital admitted patients tested positive covid-19 within 24 hours in the laboratory by rt-pcr. 2. patients with asymptomatic, mild to moderate illness of covid-19. 3. age group 18 year and above. 4. consent of the patients, wish to be included in the study willingly.